順天堂大学 · 医学研究科/医学部

研究キーワードhematologic malignancies・CAR-T cell therapy・B-cell lymphoma・acute myeloid leukemia・natural killer cell therapy・clinical hematology・myeloproliferative neoplasms

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Suzuki K, Watanabe N, Tsukune Y, Inano T, Kinoshita S, Tomoda S, Yamada K, Konishi Y, Kuwana T, Sugiyama T, Fukada K, Yamada K, Ando M, Takaku T. Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry. Sci Rep. 2025; 15: 21046.2025
• Hosoya E, Ando J, Kinoshita S, Furukawa Y, Toyoshima Y, Azusawa Y, Mitsumori T, Sato E, Takano H, Tsukune Y, Watanabe N, Takaku T, Yasuda H, Hamano Y, Sasaki M, Nojiri S, Ishii M, Ando M. Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas. Haematologica. 2025; 110: 777.2025
• Yanashima K, Furukawa Y, Ishii M, Kinoshita S, Hamano Y, Watanabe N, Tsukune Y, Yasuda H, Ando J, Ando M. Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas. EJHaem. 2025; 6: e70079.2025
• Kaito Y, Sugimoto E, Nakamura F, Tsukune Y, Sasaki M, Yui S, Yamaguchi H, Goyama S, Nannya Y, Mitani K, Tamura H, Imai Y. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. Haematologica. 2024; 109: 1107.2024

• 公式プロフィール